Nina Ank

Immunology and Microbiology · Life Sciences

8h-index2.0kcitations10works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

interferon and immune responses(8), Cytokine Signaling Pathways and Interactions(6), Immune Response and Inflammation(4), Immune Cell Function and Interaction(4), Herpesvirus Infections and Treatments(3)

Publications10 total

Forudsigelse af covid-19-belastningen på sundhedssystemet i regioner og kommuner
VBN Forskningsportal (Aalborg Universitet)·2021
Expression of Type III Interferon (IFN) in the Vaginal Mucosa Is Mediated Primarily by Dendritic Cells and Displays Stronger Dependence on NF-κB than Type I IFNs
Journal of Virology·2010· 91 citedOpen Access
Type III IFNs: New layers of complexity in innate antiviral immunity
BioFactors·2009· 98 cited
An Important Role for Type III Interferon (IFN-λ/IL-28) in TLR-Induced Antiviral Activity
The Journal of Immunology·2008· 417 cited
An important role for type III interferon (IFN-lambda/IL-28) in TLR-induced antiviral activity
Research at the University of Copenhagen (University of Copenhagen)·2008
Type I Interferon Production during Herpes Simplex Virus Infection Is Controlled by Cell-Type-Specific Viral Recognition through Toll-Like Receptor 9, the Mitochondrial Antiviral Signaling Protein Pathway, and Novel Recognition Systems
Journal of Virology·2007· 171 citedOpen Access
Type III Interferon (IFN) Induces a Type I IFN-Like Response in a Restricted Subset of Cells through Signaling Pathways Involving both the Jak-STAT Pathway and the Mitogen-Activated Protein Kinases
Journal of Virology·2007· 458 citedOpen Access
IFN-λ: Novel Antiviral Cytokines
Journal of Interferon & Cytokine Research·2006· 191 cited
Lambda Interferon (IFN-λ), a Type III IFN, Is Induced by Viruses and IFNs and Displays Potent Antiviral Activity against Select Virus Infections In Vivo
Journal of Virology·2006· 594 citedOpen Access
Age-Dependent Role for CCR5 in Antiviral Host Defense against Herpes Simplex Virus Type 2
Journal of Virology·2005· 25 citedOpen Access

Frequent Co-authors

Søren R. Paludan(8), Christina Bartholdy(3), Hans West(2), Allan Randrup Thomsen(2), Rune Hartmann(2), Marie B. Iversen(2), Frederik Dagnæs‐Hansen(2), Kevin Klucher(2), Lene Malmgaard(2), Kristina Eriksson(1), Zhangle Zhou(1), Ole J. Hamming(1), Anders Lade Nielsen(1), Peter Staeheli(1), Uffe Birk Jensen(1), Zhi Chen(1), Harald S. Haugen(1), Simon Rasmussen(1), Louise N. Sørensen(1), Joel D. Baines(1)